<?xml version="1.0"?>
<rss version="2.0">
	<channel>
		<title>News for  companies  (in Biotechnology only).</title>
		<link>http://www.lifescience-online.com/</link>
		<description>News Feed Powered by Lifescience-online.com</description>
		<language>en-us</language>
		<pubDate>Wed, 07 Jan 2009 12:27:57 +0100</pubDate>
		<lastBuildDate>Wed, 07 Jan 2009 12:27:57 +0100</lastBuildDate>
		<category>News</category>		

		<image>
			<title>Lifescience-online</title>
			<url>http://rss.lifescience-online.com/images/logo.gif</url>
			<link>http://www.lifescience-online.com/</link>
			<width></width>
			<height></height>
			<description>Lifescience-online</description>
		</image>

		<item>
			<title>BioSante Pharmaceuticals Announces Issuance of New Patent Covering Elestrin(TM)</title>
			<link>http://www.lifescience-online.com/BioSante_Pharmaceuticals_Announces_Issuance_of_New,13634.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Endocrine</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/biosante_pharmaceuticals,404.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>BIOSANTE PHARMACEUTICALS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/ESTRADIOL_GEL,615.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>ESTRADIOL GEL</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 04 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Endo Pharmaceuticals (ENDP) To Buy Indevus Pharmaceuticals, Inc. (IDEV) for $370 Million in Cash</title>
			<link>http://www.lifescience-online.com/Endo_Pharmaceuticals__ENDP__To_Buy_Indevus_Pharmac,13611.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/3/0.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Changes and Acquisitions</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/endo_pharmaceuticals_holdings,619.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ENDO PHARMACEUTICALS HOLDINGS INC</u></font></a><br /><a href='http://www.lifescience-online.com/indevus_pharmaceuticals,758.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>INDEVUS PHARMACEUTICALS INC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 04 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>XOMA (US) LLC Appoints Fred Kurland as Chief Financial Officer</title>
			<link>http://www.lifescience-online.com/XOMA__US__LLC_Appoints_Fred_Kurland_as_Chief_Finan,13618.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/2/2.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Management and Decision</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/xoma,1266.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>XOMA LTD</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 04 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Pfizer executes commercial license agreements for novel human vaccines based on Cytos Biotechnology&#039;s Immunodrug(TM) technology</title>
			<link>http://www.lifescience-online.com/Pfizer_executes_commercial_license_agreements_for_,13616.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/3.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/pfizer,651.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>PFIZER INC</u></font></a><br /><a href='http://www.lifescience-online.com/cytos_biotechnology,5481.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>CYTOS BIOTECHNOLOGY AG</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 04 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Immutep S.A. Announces Positive Interim Results in Phase I/II Chemoimmunotherapy Trial in Breast Cancer</title>
			<link>http://www.lifescience-online.com/Immutep_S_A__Announces_Positive_Interim_Results_in,13628.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/immutep_sa,5860.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>IMMUTEP SA</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/IMP-321,3999.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>IMP-321</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 04 Jan 2009 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>GTx Submits New Drug Application for Toremifene 80 mg for the Prevention of Bone Fractures in Men with Prostate Cancer on Androgen Deprivation Therapy</title>
			<link>http://www.lifescience-online.com/GTx_Submits_New_Drug_Application_for_Toremifene_80,13578.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/gtx,703.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GTX INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/TOREMIFENE,10853.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>TOREMIFENE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 29 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Immtech Pharmaceuticals, Inc. Receives Listing Notice From NYSE Alternext US</title>
			<link>http://www.lifescience-online.com/Immtech_Pharmaceuticals__Inc__Receives_Listing_Not,13605.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/8/0.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Finance stock</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/immtech_pharmaceuticals,742.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>IMMTECH PHARMACEUTICALS INC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 29 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Northfield Laboratories (NFLD) BLA for PolyHeme(R) Accepted for Filing and Granted Priority Review</title>
			<link>http://www.lifescience-online.com/Northfield_Laboratories__NFLD__BLA_for_PolyHeme_R_,13575.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Hematology</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/northfield_laboratories,954.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>NORTHFIELD LABORATORIES INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/POLYHEME,5949.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>POLYHEME</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 29 Dec 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

	</channel>
</rss>